cytisine
cytisine: developed by 1 company · 2 clinical trials tracked.
cytisine evidence translation
What we can confirm
2 tracked trials
What it means
What to watch
Prepared research question
How could cytisine → ACHV affect its developer, and what evidence supports the link?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Related indications
Study sponsors
No additional listed-company sponsor is linked.
Development Pipeline (1)
| Company | Phase |
|---|---|
| ACHIEVE LIFE SCIENCES, INC. (ACHV) Smoking Cessation | Phase 3 |
Clinical Trials (2)
Cytisine: Testing Its Potential as a Therapeutic Strategy for Smoking Cessation Among People With Concurrent Alcohol Use Disorder
Primary endpoint: Frequency and type of adverse events
A Multicenter, Double-blind, Randomized, Placebo-controlled Phase 3 Trial Evaluating the Efficacy and Safety of Cytisinicline in Adult Smokers
Primary endpoint: Percentage of Participants With Smoking Abstinence From Weeks 3 to Week 6
Frequently asked questions
Who is developing cytisine?
cytisine is being developed by ACHIEVE LIFE SCIENCES, INC..
How many clinical trials involve cytisine?
BioSniper tracks 2 clinical trials involving cytisine.